Hagen Brett R — SEC Form 4 filings
SEC reporting owner CIK 1681782. 22 Form 4 filings on record with FilingPulse; latest filed 2026-03-23.
Transaction summary — filings shown
Covers all 22 filings on record, filed 2024-01-25 to 2026-03-23. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 25 legs across 21 filings — 31,970 shares, $42,708 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 2.
- Largest priced transaction: sale of 1,915 shares @ $6.72 ($12,869) in Kalaris Therapeutics, Inc., filed 2026-03-23.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Kalaris Therapeutics, Inc. (KLRS) | Chief Accounting Officer | 22 | — | 25 legs · 31,970 sh · $42,708 | 2 |
Form 4 filings — Hagen Brett R
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-03-23 | 4 | Kalaris Therapeutics, Inc. (KLRS) | Sale (S): 1,915 @ $6.72 · Grant/award (A): 60,800 (derivative) @ $0 | EDGAR |
| 2025-04-11 | 4 | Kalaris Therapeutics, Inc. (KLRS) | Grant/award (A): 50,262 (derivative) @ $0 | EDGAR |
| 2025-03-27 | 4 | Kalaris Therapeutics, Inc. (KLRS) | Sale (S): 907 @ $8.97 | EDGAR |
| 2025-02-24 | 4 | Allovir, Inc. (ALVR) | Sale (S): 96 @ $10.08 | EDGAR |
| 2025-01-27 | 4 | Allovir, Inc. (ALVR) | Sale (S): 32 @ $9.45 · Sale (S): 4 @ $9.94 | EDGAR |
| 2025-01-13 | 4 | Allovir, Inc. (ALVR) | Sale (S): 332 @ $0.44 | EDGAR |
| 2024-11-20 | 4 | Allovir, Inc. (ALVR) | Sale (S): 554 @ $0.55 | EDGAR |
| 2024-11-06 | 4 | Allovir, Inc. (ALVR) | Sale (S): 1,655 @ $0.86 | EDGAR |
| 2024-10-23 | 4 | Allovir, Inc. (ALVR) | Sale (S): 479 @ $0.78 · Sale (S): 486 @ $0.77 | EDGAR |
| 2024-10-04 | 4 | Allovir, Inc. (ALVR) | Sale (S): 301 @ $0.81 | EDGAR |
| 2024-08-20 | 4 | Allovir, Inc. (ALVR) | Sale (S): 544 @ $0.76 | EDGAR |
| 2024-08-07 | 4 | Allovir, Inc. (ALVR) | Sale (S): 1,692 @ $0.73 | EDGAR |
| 2024-07-23 | 4 | Allovir, Inc. (ALVR) | Sale (S): 479 @ $0.75 · Sale (S): 481 @ $0.74 | EDGAR |
| 2024-07-03 | 4 | Allovir, Inc. (ALVR) | Sale (S): 304 @ $0.72 | EDGAR |
| 2024-05-21 | 4 | Allovir, Inc. (ALVR) | Sale (S): 541 @ $0.75 | EDGAR |
| 2024-05-07 | 4 | Allovir, Inc. (ALVR) | Sale (S): 1,597 @ $0.80 | EDGAR |
| 2024-04-23 | 4 | Allovir, Inc. (ALVR) | Sale (S): 473 @ $0.75 · Sale (S): 480 @ $0.75 | EDGAR |
| 2024-04-04 | 4 | Allovir, Inc. (ALVR) | Sale (S): 281 @ $0.77 | EDGAR |
| 2024-02-22 | 4 | Allovir, Inc. (ALVR) | Sale (S): 494 @ $0.70 | EDGAR |
| 2024-02-09 | 4 | Allovir, Inc. (ALVR) | Sale (S): 11,150 @ $0.67 | EDGAR |
| 2024-02-06 | 4 | Allovir, Inc. (ALVR) | Sale (S): 5,792 @ $0.67 | EDGAR |
| 2024-01-25 | 4 | Allovir, Inc. (ALVR) | Sale (S): 901 @ $0.67 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1681782 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →